Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 187.70
+6.20 (3.42%)
Aug 20, 2026, 4:09 PM HKT
Duality Biotherapeutics Revenue
In the year 2025, Duality Biotherapeutics had annual revenue of 1.85B CNY, down -4.61%. Duality Biotherapeutics had revenue of 622.80M in the half year ending December 31, 2025.
Revenue
1.85B CNY
Revenue Growth
-4.61%
P/S Ratio
8.24
Revenue / Employee
8.02M CNY
Employees
231
Market Cap
16.98B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.85B | -89.52M | -4.61% |
| Dec 31, 2024 | 1.94B | 154.72M | 8.66% |
| Dec 31, 2023 | 1.79B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Duality Biotherapeutics News
- 5 months ago - Duality Biotherapeutics Slides: Investor presentation - Filings
- 5 months ago - Duality Biotherapeutics Earnings release: H2 2025 - Filings
- 5 months ago - Duality Biotherapeutics Annual report: H2 2025 - Filings
- 1 year ago - Duality Biotherapeutics Earnings release: H1 2025 - Filings
- 1 year ago - Duality Biotherapeutics Quarterly report: H1 2025 - Filings